Mitchell P. Kopin 13D and 13G filings for Silexion Therapeutics LTD:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-21 5:49 pm Purchase |
2025-01-15 | 13G | Silexion Therapeutics LTD SLXN |
Mitchell P. Kopin | 209,827 4.990% |
209,827 (New Position) |
Filing |